Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Organism
(ORGA)
published: 10 Aug 2009
last updated: 29 Jun 2020
Suid alphaherpesvirus 1
| Kingdom | Heunggongvirae |
| Phylum | Peploviricota |
| Class | Herviviricetes |
| Order | Herpesvirales |
| Family | Herpesviridae |
| Genus | Varicellovirus |
| Species | Suid alphaherpesvirus 1 |
- Pseudorabies virus (PRV)
- Porcine herpesvirus 1
- Suid herpesvirus 1
-
SHV-1EN
I (dsDNA)
Viruses
In 1902 a Hungarian veterinarian, Aladár Aujeszky, isolated PRV from a dog, ox, and cat and showed that it caused the same disease in swine and rabbits.
EN
EN
EN
EN
Porcine alphaherpesvirus 1, which is also called pseudorabies virus (PRV) or suid herpesvirus-1 (SHV-1), causes the pseudorabies disease (also known as Aujeszky's disease, and in cattle as mad itch) which is endemic in most parts of the world.
PRV is considered to be the most economically important viral disease of swine in areas where hog cholera has been eradicated. Other domestic and wild mammals, such a cattle, sheep, dogs, raccoons are also suscetible. The disease is usually fatal in these hosts.
Research on PRV in pigs has pioneered animal disease control with genetically modified vaccines. PRV is now extensively studied as a model for basic processes during lytic herpesvirus infection, and for unravelling molecular mechanisms of herpesvirus neurotropism.
EN
PRV is considered to be the most economically important viral disease of swine in areas where hog cholera has been eradicated. Other domestic and wild mammals, such a cattle, sheep, dogs, raccoons are also suscetible. The disease is usually fatal in these hosts.
Research on PRV in pigs has pioneered animal disease control with genetically modified vaccines. PRV is now extensively studied as a model for basic processes during lytic herpesvirus infection, and for unravelling molecular mechanisms of herpesvirus neurotropism.
- Vaccine
EN
| Record type | Field | Record(s) | |
|---|---|---|---|
| Living Modified Organism | Recipient Organism or Parental Organisms | 1 | |
| Genetic element | Donor organism (scientific name) | 2 | |